These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11499964)

  • 1. The genetic variability of HIV-1 and its implications.
    Peeters M
    Transfus Clin Biol; 2001 Jun; 8(3):222-5. PubMed ID: 11499964
    [No Abstract]   [Full Text] [Related]  

  • 2. The clades of HIV: their origins and clinical significance.
    Stebbing J; Moyle G
    AIDS Rev; 2003; 5(4):205-13. PubMed ID: 15011999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation, chimpanzees, and the origin of AIDS.
    Reines BP
    Perspect Biol Med; 1996; 39(2):187-92. PubMed ID: 8820538
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction of HIV drug-resistance testing in clinical practice.
    Rodríguez-Rosado R; Briones C; Soriano V
    AIDS; 1999 Jun; 13(9):1007-14. PubMed ID: 10397528
    [No Abstract]   [Full Text] [Related]  

  • 6. Diversity considerations in HIV-1 vaccine selection.
    Gaschen B; Taylor J; Yusim K; Foley B; Gao F; Lang D; Novitsky V; Haynes B; Hahn BH; Bhattacharya T; Korber B
    Science; 2002 Jun; 296(5577):2354-60. PubMed ID: 12089434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of drug resistance-related mutations among HIV-1s in Japan.
    Sugiura W; Matsuda M; Abumi H; Yamada K; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takada N; Kakishita E; Yoshioka A; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Feb; 52(1):21-2. PubMed ID: 10808258
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy.
    Deminie CA; Bechtold CM; Riccardi K; Rose RE; Samanta H; Lin PF; Colonno RJ
    AIDS; 1998 Jan; 12(1):110-2. PubMed ID: 9456262
    [No Abstract]   [Full Text] [Related]  

  • 9. The challenge of HIV-1 subtype diversity.
    Taylor BS; Sobieszczyk ME; McCutchan FE; Hammer SM
    N Engl J Med; 2008 Apr; 358(15):1590-602. PubMed ID: 18403767
    [No Abstract]   [Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
    Buonaguro L; Tornesello ML; Buonaguro FM
    J Virol; 2007 Oct; 81(19):10209-19. PubMed ID: 17634242
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV/AIDS Vaccines: 2018.
    Robinson HL
    Clin Pharmacol Ther; 2018 Dec; 104(6):1062-1073. PubMed ID: 30099743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent aspects of HIV and HIV-related diseases.
    Gürtler L
    Infection; 1997; 25(2):71-3. PubMed ID: 9108178
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual HIV infection.
    Cheonis N
    BETA; 2006; 18(2):36-40. PubMed ID: 16610118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins of HIV and the evolution of resistance to AIDS.
    Heeney JL; Dalgleish AG; Weiss RA
    Science; 2006 Jul; 313(5786):462-6. PubMed ID: 16873637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping HIV isolates paves the way to effective treatment regimes.
    Sansom C
    Mol Med Today; 1999 Oct; 5(10):417. PubMed ID: 10498906
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus and ancestral state HIV vaccines.
    Nickle DC; Jensen MA; Gottlieb GS; Shriner D; Learn GH; Rodrigo AG; Mullins JI
    Science; 2003 Mar; 299(5612):1515-8; author reply 1515-8. PubMed ID: 12624248
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization and challenge of chimpanzees with HIV-1.
    Fultz PN
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1517-9. PubMed ID: 1466994
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
    Vanhems P; Gaudet R; Hirschel B; Imrie A; Conway B; Rouleau D; Vizzard J; Perrin L; Cooper DA; Yerly S
    AIDS; 2000 May; 14(8):1065-7. PubMed ID: 10853993
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on the human immunodeficiency virus.
    Brun-Vézinet F; Charpentier C
    Med Mal Infect; 2013 May; 43(5):177-84. PubMed ID: 23628423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.